Drug intelligence / Profile preview

Cartipep

Development stage
Unknown
Lead developer
Nitta Gelatin India
Modality
Small Molecules, Peptides
Administration
Oral
01

Overview

Cartipep is a nutritional supplement and biologic formulation developed by Anthus Pharmaceuticals in collaboration with Nitta Gelatin for the management of osteoarthritis and joint disorders. It contains a combination of 10g of bioactive collagen peptides and 40mg of Vitamin C (ascorbic acid). The product is designed to support the regeneration of joint cartilage and reduce pain by providing the necessary amino acid building blocks for the extracellular matrix and facilitating the enzymatic synthesis of new collagen fibers. Vitamin C is included as an essential cofactor for the hydroxylation of proline and lysine residues during endogenous collagen synthesis. It is typically administered orally as a sachet and is marketed in India as a complete therapy for joint health and cartilage support.

Brand names
CartipepNew Cartipep
Other names
collagen peptide + Vitamin C
02

Targets

PHD1 (Prolyl hydroxylase domain-containing protein 1)

Beyond the preview

Go deeper on Cartipep.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cartipep.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call